검색어 : 통합검색[Orr Rebecca B.]
총 76건 중 76건 출력
, 3/8 페이지
-
21
- Exposure to family and domestic violence in the prenatal period is associated with an increased risk of hospitalization for bronchiolitis in children under 2 years
- Orr, Carol; Kelty, Erin; Belinelo, Patricia; Fisher, Colleen; Glauert, A Rebecca; O’Donnell, Melissa; Preen, David B; School of Population and Global Health, The University of Western Australia , Perth, Western Australia 6009, Australia; School of Population and Global Health, The University of Western Australia , Perth, Western Australia 6009, Australia; The School of Medicine, University of Notre Dame , Fremantle, Western Australia 6160, Australia; School of Population and Global Health, The University of Western Australia , Perth, Western Australia 6009, Australia; School of Population and Global Health, The University of Western Australia , Perth, Western Australia 6009, Australia; The University of South Australia Australian Centre for Child Protection, , Adelaide, South Australia 5000, Australia; School of Population and Global Health, The University of Western Australia , Perth, Western Australia 6009, Australia; (Journal of public health, v.46, 2024, pp.e448-e457)
-
22
- Abstract OT-03-09: Trastuzumab deruxtecan (T-DXd; DS-8201) vs investigator’s choice of chemotherapy in patients with hormone receptor-positive (HR+), HER2 low metastatic breast cancer whose disease has progressed on endocrine therapy in the metastatic setting: A randomized, global phase 3 trial (DESTINY-Breast06)
- Bardia, Aditya; Barrios, Carlos; Dent, Rebecca; Hu, Xichun; O’Shaughnessy, Joyce; Yonemori, Kan; Darilay, Annie; Boston, Sarice; Liu, Yufan; Patel, Gargi; Curigliano, Giuseppe; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.OT-03-09-OT-03-09)
-
23
- Abstract PD7-03: Translational Breast Cancer Research Consortium Trial 022: Neratinib and Trastuzumab-Emtansine for HER2+ Breast Cancer Brain Metastases (BCBM)
- Freedman, Rachel; Ren, Siyang; Tayob, Nabihah; Gelman, Rebecca; Smith, Karen L.; Davis, Raechel; Pereslete, Alyssa; Attaya, Victoria; Cotter, Christine; Chen, Wendy Y.; Santa-Maria, Cesar Augusto; Van Poznak, Catherine; Moy, Beverly; Brufsky, Adam M.; Melisko, Michelle; O’Sullivan, Ciara C.; Ashai, Nadia; Rauf, Yasmeen; Nangia, Julie; Trapani, Dario; Savoie, Jennifer; Burns, Robyn; Wolff, Antonio C.; Winer, Eric; Rimawi, Mothaffar; Krop, Ian; Lin, Nancy U.; 1Dana-Farber Cancer Institute, Massachusetts; 2Dana-Farber Cancer Institute; 3Dana-Farber Cancer Institute, Boston, MA; 4Dana-Farber Cancer Institute; 5Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; 6Dana-Farber Cancer Institute; 7Dana-Farber Cancer Institute; 8Dana-Farber Cancer Institute; 9Dana-Farber Cancer Institute; 10Dana-Farber Cancer Institute; 11Johns Hopkins; 12University of Michigan; 13Massachusetts General Hospital; 14UPMC Hillman Cancer Center, University of Pittsburgh Medical Center; 15University of California at San Francisco, San Francisco, California; 16Mayo Clinic, Rochester, MN, ROCHESTER, Minnesota; 17MedStar/Georgetown University; 18University of North Carolina; 19Baylor College of Medicine; 20Dana-Farber Cancer Institute, Massachusetts; 21Translational Breast Cancer Research Consortium; 22Translational Breast Cancer Research Consortium; 23Johns Hopkins University, Baltimore, Baltimore, Maryland; 24Yale Cancer Center, New Haven, CT; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.PD7-03-PD7-03)
-
24
- Abstract CT061: Binimetinib in patients with tumors with <i>NRAS</i> mutations: NCI-MATCH ECOG-ACRIN Cancer Research Group subprotocol EAY131-Z1A
- Cleary, James M.; Wang, Victoria; Heist, Rebecca; Kopetz, Scott; Mitchell, Edith P.; Zwiebel, James; Chen, Helen X.; Li, Shuli; Gray, Robert; McShane, Lisa; Rubinstein, Larry; Patton, David; Meric-Bernstam, Funda; Dillmon, Melissa; Williams, Mickey; Hamilton, Stanley; Conley, Barbara; O'Dwyer, Peter; Harris, Lyndsay; Arteaga, Carlos; Chen, Alice; Flaherty, Keith; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.80, 2020, pp.CT061-CT061)
-
25
- Abstract 974: Phase II trial of the Wee1 inhibitor adavosertib in advanced refractory solid tumors with CCNE1 amplification
- Fu, Siqing; Yao, Shuyang; Yuan; Previs, Rebecca A.; Elias, Anthony D.; Carvajal, Richard; George, Thomas J.; Yuan, Ying; Yamamura, Yuko; Westin, Shannon; Xing, Yan; Dumbrava, Ecaterina E. Ileana; Karp, Daniel D.; Piha-Paul, Sarina A.; Tsimberidou, Apostolia M.; Rodon, Jordi; Takebe, Naoko; Kunos, Charles; Lu, Karen; Keyomarsi, Khanda; Meric-Bernstam, Funda; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.974-974)
-
26
- Abstract CT048: Phase 1/2 study of olaparib tablets and temozolomide in patients with small cell lung cancer (SCLC) following failure of prior chemotherapy
- Farago, Anna F.; Drapkin, Benjamin J.; Charles, Allison; Yeap, Beow; Heist, Rebecca S.; Azzoli, Christopher G.; Jackman, David M.; Barbie, David A.; Choy, Edwin; Sequist, Lecia V.; Maheswaran, Shyamala; Haber, Daniel A.; Hata, Aaron N.; Dyson, Nicholas; Shaw, Alice T.; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.77, 2017, pp.CT048-CT048)
-
27
- Abstract CT082: Capmatinib in <i>MET</i>ex14-mutated (mut) advanced non-small cell lung cancer (NSCLC): Results from the phase II GEOMETRY <i>mono-1</i> study, including efficacy in patients (pts) with brain metastases (BM)
- Garon, Edward B.; Heist, Rebecca S.; Seto, Takashi; Han, Ji-Youn; Reguart, Noemi; Groen, Harry J.; Tan, Daniel SW; Hida, Toyoaki; de Jonge, Maja J.; Orlov, Sergey V.; Smit, Egbert F.; Souquet, Pierre-Jean; Vansteenkiste, Johan; Mouhaer, Sylvie Le; Robeva, Anna; Waldron-Lynch, Maeve; Giovannini, Monica; Wolf, Juergen; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.80, 2020, pp.CT082-CT082)
-
28
- Children exposed to family and domestic violence perpetrated against their mother are at an increased risk of emergency department attendance in childhood
- Carol Orr; Scott Sims; Colleen M Fisher; Melissa O' Donnell; Rebecca A Glauert; David B Preen; The School of Population and Global Health, The University of Western Australia Perth Western Australia Australia; The School of Population and Global Health, The University of Western Australia Perth Western Australia Australia; The School of Population and Global Health, The University of Western Australia Perth Western Australia Australia; The Australian Centre for Child Protection, The University of South Australia Adelaide South Australia Australia; Raine Study, The University of Western Australia Perth Western Australia Australia; The School of Population and Global Health, The University of Western Australia Perth Western Australia Australia; (Emergency Medicine Australasia, v., 2025, )
-
29
- Abstract LB056: Accurate detection of <i>MET</i> exon 14 skipping using a liquid biopsy assay in NSCLC patients in the GEOMETRY mono-1 study
- Heist, Rebecca S.; Garon, Edward B.; Tan, Daniel S.; Groen, Harry J.; Seto, Takashi; Smit, Egbert F.; Zou, Mike; Yang, Yiqun; Li, Ying; Agostinho, Andrea Chassot; Wolf, Juergen; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.LB056-LB056)
-
30
- Abstract OT1-03-05: TROPION-Breast02: Phase 3, open-label, randomized study of first-line datopotamab deruxtecan versus chemotherapy in patients with locally recurrent inoperable or metastatic TNBC who are not candidates for anti-PD-(L)1 therapy
- Dent, Rebecca; Cescon, David W.; Bachelot, Thomas; Jung, Kyung Hae; Shao, Zhi-Ming; Saji, Shigehira; Traina, Tiffany A.; Vuković , Petra; Mapiye, Darlington; Maxwell, Micah; Schmid, Peter; Corté s, Javier; 1National Cancer Centre Singapore, Singapore; 2Princess Margaret Cancer Centre/UHN, Canada; 3Centre Lé on Bé rard, Lyon, France; 4Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 5Fudan University Shanghai Cancer Center; 6Fukushima Medical University, Fukushima, Japan; 7Memorial Sloan Kettering Cancer Center; 8AstraZeneca, Cambridge, United Kingdom; 9AstraZeneca, Cambridge, United Kingdom; 10Global Development Medical Director - AstraZeneca, Gaithersburg, Maryland; 11Bart’s Cancer Institute, London, United Kingdom; 12International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Madrid and Barcelona, Spain & Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.OT1-03-05-OT1-03-05)
QUICK MENU
